Metabolic, behavioral health, and disordered eating comorbidities associated with obesity in pediatric patients: An Obesity Medical Association (OMA) Clinical Practice Statement 2022

Disordered Eating and Eating Disorders in Pediatric Obesity: Assessment and Next Steps

“…The effects of DEBs on pediatric obesity and overall health may vary [9]. For example, LOC or binge eating episodes characterized by palatable foods comprised of refined, processed carbohydrates and saturated fat can affect conditions like diabetes, hepatic steatosis, and dyslipidemia [24]. LOC eating is also associated with and predictive of psychological symptoms, high weight, and worsened cardiometabolic health [25].…”

“…However, DEBs typically differ from eating disorders in the frequency and severity of symptoms such that the risk for eating-related laboratory complications is low. Nonetheless, DEBs undermine obesity treatment by contributing to patterns of weight gain, avoidance of physical activity, or feelings of shame and guilt [9,24,27].…”

“…Obesity medicine providers can ensure holistic care by addressing issues with sleep, recommending behavioral or pharmacotherapy for mood and behavior disorders, and advocating for the use of weight-neutral medications or finding alternatives to weight-promoting medications [24,55]. Children and adolescents with concomitant obesity and disordered eating behaviors can generally be managed in primary care or by the multidisciplinary weight management team [54].…”

Special considerations for the adolescent with obesity: An obesity medicine association (OMA) clinical practice statement (CPS) 2024

“…We now have recommendations for pediatric obesity treatment that include multiple forms of IHBLT, AOMs, MBS, and combination therapy [ [17] , [18] , [19] , [61] , [62] , [63] , [64] , [65] ]. All of the recommendations use IHBLT either alone or as a background to the other forms of therapy.…”

Obesity, thrombosis, venous disease, lymphatic disease, and lipedema: An obesity medicine association (OMA) clinical practice statement (CPS) 2023

“…In addition to Obesity Medicine Association (OMA) Position Statements [ 1 , 2 ], the OMA has published a series of Clinical Practice Statements, reviews, and round-table discussions regarding obesity-related diagnostic and treatment consideration of cardiometabolic topics such as nutrition [ 3 ], physical activity [ 3 ], pediatrics [ [4] , [5] , [6] ], race/ethnicities [ [7] , [8] , [9] , [10] ], body composition [ 11 , 12 ], behavior modification [ 13 ], anti-obesity medications [ [14] , [15] , [16] ], concomitant medications [ 17 ], diabetes mellitus [ 18 ], hypertension [ 19 ], mental stress [ 20 ], sleep apnea [ 21 ], and bariatric surgery [ 22 ]. This OMA Clinical Practice Statement explores the relationship between obesity and thrombosis, venous disease, lymphatic disease, and lipedema.…”